KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We've All Been Waiting For. [PDF]
Stanger BZ, Vonderheide RH.
europepmc +1 more source
Targeting GLP1 receptor for reducing global cardiovascular risk. [PDF]
Curcio A +4 more
europepmc +1 more source
Glucagon-like Peptide-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control. [PDF]
Xanthopoulou M +10 more
europepmc +1 more source
Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib. [PDF]
Kawczak P, Bączek T.
europepmc +1 more source
The promises and challenges of robotic-assisted surgery in regional Australia. [PDF]
Hsueh YH +7 more
europepmc +1 more source
Robotic Surgical Training in the Northern Deanery: A trainee-led evaluation in line with GIRFT recommendations. [PDF]
Saunders J +6 more
europepmc +1 more source
The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis. [PDF]
Sasaki T +6 more
europepmc +1 more source
Systematic and precise interventions for KRAS-mutant cancers. [PDF]
Liang J +5 more
europepmc +1 more source
Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT). [PDF]
Hachizovu S +19 more
europepmc +1 more source

